Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst

Journal of Cystic Fibrosis

Volumn 12, Issue 4, 2013, Pages 352-362

  Houston, Neralee ^a,b   Stewart, Niall ^b   Smith, Daniel S ^a,c   Bell, Scott C ^c,d   Champion, Alan C ^b,e   Reid, David W ^a,b,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d Queensland Children's Medical Research Institute   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cystic fibrosis; Neutrophils; Oxidative stress; Respiratory burst; ROS production

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT; AIRWAY; APOPTOSIS; ARTICLE; BLOOD; CELL VIABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG FUNCTION; MALE; NEUTROPHIL; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RESPIRATORY BURST; SPUTUM; SPUTUM ANALYSIS; STAINING;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; RESPIRATORY BURST; SPUTUM; YOUNG ADULT;

EID: 84878355344     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.11.004     Document Type: Article

References (55)

1. Kennedy A.D., DeLeo F.R. Neutrophil apoptosis and the resolution of infection. Immunol Res 2009, 43:25-61.
2. Maderna P., Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 2003, 1639:141-151.
3. Vandivier R.W., Henson P.M., Douglas I.S. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006, 129:1673-1682.
4. Watt A.P., Courtney J., Moore J., Ennis M., Elborn J.S. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005, 60:659-664.
5. Vandivier R.W., Fadok V.A., Hoffmann P.R., Bratton D.L., Penvari C., Brown K.K., et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002, 109:661-670.
6. Hartl D., Latzin P., Hordijk P., Marcos V., Rudolph C., Woischnik M., et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007, 13:1423-1430.
7. Reid D.W., Misso N., Aggarwal S., Thompson P.J., Walters E.H. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis. Respirology 2007, 12:63-69.
8. Usher L.R., Lawson R.A., Geary I., Taylor C.J., Bingle C.D., Taylor G.W., et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002, 168:1861-1868.
9. Fruhwirth M., Ruedl C., Ellemunter H., Bock G., Wolf H. Flow-cytometric evaluation of oxidative burst in phagocytic cells of children with cystic fibrosis. Int Arch Allergy Immunol 1998, 117:270-275.
10. Efthimiadis A., Pizzichini M.M., Pizzichini E., Dolovich J., Hargreave F.E. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. Eur Respir J 1997, 10:1336-1340.
11. Hector A., Jonas F., Kappler M., Feilcke M., Hartl D., Griese M. Novel method to process cystic fibrosis sputum for determination of oxidative state. Respiration 2010, 80:393-400.
12. Louis R., Shute J., Goldring K., Perks B., Lau L.C., Radermecker M., et al. The effect of processing on inflammatory markers in induced sputum. Eur Respir J 1999, 13:660-667.
13. Woolhouse I.S., Bayley D.L., Stockley R.A. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002, 57:667-671.
14. Alvarez-Larran A., Toll T., Rives S., Estella J. Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol 2005, 27:41-46.
15. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol 1990, 47:440-448.
16. van Eeden S.F., Klut M.E., Walker B.A., Hogg J.C. The use of flow cytometry to measure neutrophil function. J Immunol Methods 1999, 232:23-43.
17. Elbim C., Lizard G. Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations. Cytometry A 2009, 75:475-481.
18. Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 2010, 594:57-72.
19. Whiteman M., Dogra Y., Winyard P.G., Armstrong J.S. Detection and measurement of reactive oxygen intermediates in mitochondria and cells. Methods Mol Biol 2009, 476:28-49.
20. Smith J.A., Weidemann M.J. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 1993, 162:261-268.
21. Robinson J.P. Oxidative metabolism unit 9.7 current protocols in cytometry 1997, John Wiley & Sons, Inc.
22. Birrer P., McElvaney N.G., Rudeberg A., Sommer C.W., Liechti-Gallati S., Kraemer R., et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994, 150:207-213.
23. Brown R.K., Wyatt H., Price J.F., Kelly F.J. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996, 9:334-339.
24. Downey D.G., Brockbank S., Martin S.L., Ennis M., Elborn J.S. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol 2007, 42:729-735.
25. McKeon D.J., Condliffe A.M., Cowburn A.S., Cadwallader K.C., Farahi N., Bilton D., et al. Prolonged survival of neutrophils from patients with Delta F508 CFTR mutations. Thorax 2008, 63:660-661.
26. Adib-Conquy M., Pedron T., Petit-Bertron A.F., Tabary O., Corvol H., Jacquot J., et al. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 2008, 14:36-44.
27. Moriceau S., Lenoir G., Witko-Sarsat V. In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Immun 2010, 2:260-266. [Epub 2010/04/09].
28. Moriceau S., Kantari C., Mocek J., Davezac N., Gabillet J., Guerrera I.C., et al. Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients. J Immunol 2009, 182:7254-7263. [Epub 2009/05/21].
29. Tabary O., Corvol H., Boncoeur E., Chadelat K., Fitting C., Cavaillon J.M., et al. Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions. Am J Physiol Lung Cell Mol Physiol 2006, 290:L588-L596.
30. Tirouvanziam R., Gernez Y., Conrad C.K., Moss R.B., Schrijver I., Dunn C.E., et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A 2008, 105:4335-4339.
31. Duffin R., Leitch A.E., Fox S., Haslett C., Rossi A.G. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 2010, 236:28-40.
32. Christenson K., Bjorkman L., Karlsson J., Sundqvist M., Movitz C., Speert D.P., et al. In vivo-transmigrated human neutrophils are resistant to antiapoptotic stimulation. J Leukoc Biol 2011, 90:1055-1063. [Epub 2011/06/24].
33. Zarember K.A., Kuhns D.B. Editorial: will the real neutrophil please stand up?. J Leukoc Biol 2011, 90:1039-1041. [Epub 2011/12/02].
34. Makam M., Diaz D., Laval J., Gernez Y., Conrad C.K., Dunn C.E., et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A 2009, 106:5779-5783.
35. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31:1-9.
36. Liu G., Wang J., Park Y.J., Tsuruta Y., Lorne E.F., Zhao X., et al. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 2008, 181:4240-4246.
37. Peter C., Wesselborg S., Herrmann M., Lauber K. Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells. Apoptosis 2010, 15:1007-1028.
38. Rowe S.M., Jackson P.L., Liu G., Hardison M., Livraghi A., Solomon G.M., et al. Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 2008, 178:822-831.
39. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 2007, 35:1147-1150.
40. Hampton M.B., Orrenius S. Redox regulation of apoptotic cell death in the immune system. Toxicol Lett 1998, 102-103:355-358.
41. McConkey D.J. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 1998, 99:157-168.
42. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett 1996, 378:107-110.
43. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
44. Brinkmann V., Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007, 5:577-582.
45. Fuchs T.A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007, 176:231-241.
46. Marcos V., Zhou Z., Yildirim A.O., Bohla A., Hector A., Vitkov L., et al. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med 2010, 16:1018-1023.
47. Medina E. Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. J Innate Immun 2009, 1:176-180.
48. Fadeel B., Kagan V.E. Apoptosis and macrophage clearance of neutrophils: regulation by reactive oxygen species. Redox Rep 2003, 8:143-150.
49. Anderson H.A., Englert R., Gursel I., Shacter E. Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. Cell Death Differ 2002, 9:616-625.
50. Lee Y.J., Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999, 274:19792-19798.
51. Hudson V.M. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med 2001, 30:1440-1461.
52. Roum J.H., Buhl R., McElvaney N.G., Borok Z., Crystal R.G. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993, 75:2419-2424.
53. Tirouvanziam R., Conrad C.K., Bottiglieri T., Herzenberg L.A., Moss R.B. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci U S A 2006, 103:4628-4633. [Epub 2006/03/16].
54. Alexis N., Soukup J., Ghio A., Becker S. Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol 2000, 97:21-32.
55. Elborn J.S., Cordon S.M., Parker D., Delamere F.M., Shale D.J. The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Respir Med 1993, 87:603-607. [Epub 1993/11/01].